CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

Mckesson Corp, CVS Health Corp and Pfizer Inc at JPMorgan Healthcare Conference (Virtual) - Keynote Panel: COVID-19 Vaccines: From the Lab to Your Arm Transcript

Jan 13, 2021 / 05:45PM GMT
Release Date Price: R$39.85 (-2.05%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

All right. Good afternoon, everyone, and welcome to JPMorgan's 39th Annual Healthcare Conference. Sorry for the short delay getting started. My name is Cory Kasimov. I'm a senior biotech analyst here. And I'm joined by my colleagues, Lisa Gill, our health care technology and distribution analyst; and Chris Schott, our U.S. pharmaceuticals analyst. And it's our pleasure to host this keynote on all things related to COVID-19 vaccines.

We're very excited to have a really distinguished group of panelists today, including Dr. Moncef Slaoui, the Chief Adviser to Operation Warp Speed; Angela Hwang, Group President of Pfizer Biopharmaceuticals; Stéphane Bancel, the CEO of Moderna; Karen Lynch, the current President of Aetna and incoming CEO of CVS Health; and Brian Tyler, the CEO of McKesson.

So thanks to you all for taking the time to join us today. And even more so, I think I should speak for everyone when I say upfront, thank you for all your efforts in fighting this pandemic. So our hope with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot